485 related articles for article (PubMed ID: 27561949)
21. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
22. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
23. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
[No Abstract] [Full Text] [Related]
24. Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.
He QZ; Luo XZ; Wang K; Zhou Q; Ao H; Yang Y; Li SX; Li Y; Zhu HT; Duan T
Cell Physiol Biochem; 2014; 33(1):173-84. PubMed ID: 24504111
[TBL] [Abstract][Full Text] [Related]
25. TRRAP stimulates the tumorigenic potential of ovarian cancer stem cells.
Kang KT; Kwon YW; Kim DK; Lee SI; Kim KH; Suh DS; Kim JH
BMB Rep; 2018 Oct; 51(10):514-519. PubMed ID: 29936929
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
27. Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties.
Hirst J; Pathak HB; Hyter S; Pessetto ZY; Ly T; Graw S; Koestler DC; Krieg AJ; Roby KF; Godwin AK
Cancer Res; 2018 Aug; 78(15):4370-4385. PubMed ID: 29891506
[TBL] [Abstract][Full Text] [Related]
28. Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
Wang Y; Zhao G; Condello S; Huang H; Cardenas H; Tanner EJ; Wei J; Ji Y; Li J; Tan Y; Davuluri RV; Peter ME; Cheng JX; Matei D
Cancer Res; 2021 Jan; 81(2):384-399. PubMed ID: 33172933
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.
Nam EJ; Lee M; Yim GW; Kim JH; Kim S; Kim SW; Kim YT
BMC Med Genomics; 2012 May; 5():18. PubMed ID: 22643117
[TBL] [Abstract][Full Text] [Related]
33. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels.
Puca F; Colamaio M; Federico A; Gemei M; Tosti N; Bastos AU; Del Vecchio L; Pece S; Battista S; Fusco A
Oncotarget; 2014 May; 5(10):3234-45. PubMed ID: 24833610
[TBL] [Abstract][Full Text] [Related]
34. Protein tyrosine phosphatase PTPN3 promotes drug resistance and stem cell-like characteristics in ovarian cancer.
Li S; Cao J; Zhang W; Zhang F; Ni G; Luo Q; Wang M; Tao X; Xia H
Sci Rep; 2016 Nov; 6():36873. PubMed ID: 27833130
[TBL] [Abstract][Full Text] [Related]
35. Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells.
Zhang Y; Sun B; Zhao X; Sun H; Cui W; Liu Z; Yao X; Dong X
J Exp Clin Cancer Res; 2016 Oct; 35(1):163. PubMed ID: 27756344
[TBL] [Abstract][Full Text] [Related]
36. Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance.
Ward Rashidi MR; Mehta P; Bregenzer M; Raghavan S; Fleck EM; Horst EN; Harissa Z; Ravikumar V; Brady S; Bild A; Rao A; Buckanovich RJ; Mehta G
Neoplasia; 2019 Aug; 21(8):822-836. PubMed ID: 31299607
[TBL] [Abstract][Full Text] [Related]
37. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
[TBL] [Abstract][Full Text] [Related]
38. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
[TBL] [Abstract][Full Text] [Related]
39. Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells.
Lee JW; Sung JS; Park YS; Chung S; Kim YH
Gastric Cancer; 2019 Sep; 22(5):967-979. PubMed ID: 30726523
[TBL] [Abstract][Full Text] [Related]
40. Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.
Dou J; Jiang C; Wang J; Zhang X; Zhao F; Hu W; He X; Li X; Zou D; Gu N
Cell Biol Int; 2011 Mar; 35(3):227-34. PubMed ID: 21108606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]